Pallone Drafting Drug Pricing Bill With Medicare Price Negotiation, Exclusivity Penalties, Transparency Requirements

July 20, 2017 at 6:21 PM
Correction Appended House Energy & Commerce ranking Democrat Frank Pallone (NJ) is writing drug pricing legislation that includes a laundry list of policies, including revoking exclusivity when companies promote off-label uses or otherwise break the law, allowing Medicare price negotiation by repealing the noninterference clause, imposing penalties for misclassification under the Medicaid rebate program and requiring price transparency. Pallone revealed during a drug pricing event at the Center For American Progress Monday (July 17) that he intends...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.